news
FDA approves Aimovig as a preventive treatment for migraines
The FDA has approved Aimovig for the preventive treatment of a migraine in adults. The treatment is given by once-monthly self-injections...
List view / Grid view
Drug Targets
news
Eczema drug effective against severe asthma
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies...
news
Ebselen provides promising new avenue for treatment of MND
An international study has shown that the drug-molecule ebselen can correct many of the toxic characteristics of a protein that causes some cases of hereditary motor neurone disease...
news
TXA may benefit stroke patients
Patients with stroke caused by bleeding on the brain may benefit from receiving a drug currently used to treat blood loss from major trauma and bleeding after childbirth...
news
Diabetes drugs show promise to treat symptoms of Alzheimer’s
Discovery of a pathway linking Alzheimer's disease and Type 2 diabetes leads to new strategies to preserve brain health...
news
FDA approves first epoetin alfa biosimilar for the treatment of anaemia
The FDA has approved Retacrit as a biosimilar to Epogen/Procrit for the treatment of anaemia caused by chronic kidney disease, chemotherapy, or use of zidovudine in patients with HIV infection...
news
SB216763 shows efficacy in Rett syndrome
Researchers describe how a new drug is able to reduce the symptoms and activate the dormant neurons characteristic of Rett Syndrome...
news
PET scan tracer predicts success of cancer vaccine
By engineering a special molecule to track certain immune cells in the body, scientists have invented a litmus test for the effectiveness of a newly devised cancer therapy...
news
Noninvasive therapy may reverse atherosclerosis
Researchers synthesized self-assembling peptide amphile nanofibers that targeted areas of plaque and could be delivered by intravenous injection...
news
FDA grants fast track designation for a Chikungunya vaccine
Fast Track program is designed to facilitate development and expedite review of therapies and vaccines to address unmet health needs...
news
Scientists identify cause of resistance to breast and ovarian cancer drug
Scientists have identified a mutation that gives cancer cells resistance to the breakthrough cancer treatment olaparib and other PARP inhibitors...
news
Bacteria therapy shows promise for eczema
Topical treatment with live Roseomonas mucosa was found to be safe for adults and children with atopic dermatitis...
news
Celecoxib shows potential benefit for Duchenne muscular dystrophy
Researchers have found that the FDA-approved anti-inflammatory drug Celecoxib had beneficial effects on the muscle function in muscular dystrophy...
news
Zoledronic acid could be used to treat basal-like breast cancer
Researchers have discovered that an enzyme called UGT8 drives the progression of basal-like breast cancer...
news
FDA approves Tafinlar/Mekinist for BRAF V600-mutant melanoma
The FDA has approved Tafinlar in combination with Mekinist for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutation...
